Aptorum Group Reports Decreased Annual Loss
Has released an update. Aptorum Group, a biopharmaceutical company, has reported a decreased net loss of $4.3 million for the f...
Stay updated with breaking news from Daptorum Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Has released an update. Aptorum Group, a biopharmaceutical company, has reported a decreased net loss of $4.3 million for the f...
Aptorum Group Limited , a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced financial...
Aptorum Group Limited (NASDAQ:APM – Get Free Report) was the target of a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 41,000 shares, a drop of 58.4% from the March 31st total of 98,500 shares. Currently, 1.9% of the company’s shares are short sold. […]
Aptorum Group Limited (NASDAQ:APM – Get Free Report) was the recipient of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 128,900 shares, an increase of 42,866.7% from the February 29th total of 300 shares. Based on an average daily volume of 2,310,000 shares, […]
Aptorum Group Limited (NASDAQ:APM – Get Free Report) was the target of a significant increase in short interest in January. As of January 31st, there was short interest totalling 3,800 shares, an increase of 81.0% from the January 15th total of 2,100 shares. Approximately 0.2% of the company’s shares are sold short. Based on an […]